Phibro Animal Health Corp (PAHC) Major Shareholder Bfi Co., Llc Sells 10,000 Shares

Phibro Animal Health Corp (NASDAQ:PAHC) major shareholder Bfi Co., Llc sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $46.60, for a total transaction of $466,000.00. Following the completion of the transaction, the insider now directly owns 17,470 shares of the company’s stock, valued at approximately $814,102. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Bfi Co., Llc also recently made the following trade(s):

  • On Thursday, June 7th, Bfi Co., Llc sold 30,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $46.06, for a total transaction of $1,381,800.00.
  • On Friday, May 25th, Bfi Co., Llc sold 2,600 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.09, for a total transaction of $117,234.00.
  • On Friday, May 18th, Bfi Co., Llc sold 9,930 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.05, for a total transaction of $447,346.50.

Shares of Phibro Animal Health traded up $0.50, hitting $47.00, during trading on Thursday, Marketbeat Ratings reports. 5,051 shares of the stock were exchanged, compared to its average volume of 100,666. The stock has a market cap of $1.89 billion, a P/E ratio of 30.93, a price-to-earnings-growth ratio of 2.78 and a beta of 0.94. Phibro Animal Health Corp has a 12-month low of $32.05 and a 12-month high of $48.40. The company has a current ratio of 3.17, a quick ratio of 1.73 and a debt-to-equity ratio of 1.61.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Monday, May 7th. The company reported $0.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.02. The business had revenue of $209.00 million during the quarter, compared to analysts’ expectations of $203.03 million. Phibro Animal Health had a net margin of 7.24% and a return on equity of 39.91%. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.37 EPS. sell-side analysts forecast that Phibro Animal Health Corp will post 1.71 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 27th. Stockholders of record on Wednesday, June 6th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, June 5th. This represents a $0.40 annualized dividend and a dividend yield of 0.85%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 26.49%.

Several equities analysts have commented on the stock. Zacks Investment Research cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Thursday, May 10th. Credit Suisse Group raised their price target on shares of Phibro Animal Health from $39.00 to $42.00 and gave the company a “neutral” rating in a research report on Wednesday, May 9th. BidaskClub raised shares of Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, March 3rd. Finally, ValuEngine raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $38.80.

Institutional investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. lifted its position in shares of Phibro Animal Health by 17.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock worth $15,959,000 after purchasing an additional 69,063 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its position in shares of Phibro Animal Health by 37.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock worth $8,159,000 after purchasing an additional 66,300 shares during the last quarter. Investors Research Corp purchased a new stake in shares of Phibro Animal Health during the 4th quarter worth $433,000. Prudential Financial Inc. lifted its position in shares of Phibro Animal Health by 37.7% during the 1st quarter. Prudential Financial Inc. now owns 189,070 shares of the company’s stock worth $7,506,000 after purchasing an additional 51,800 shares during the last quarter. Finally, Arizona State Retirement System lifted its position in shares of Phibro Animal Health by 229.1% during the 4th quarter. Arizona State Retirement System now owns 32,914 shares of the company’s stock worth $1,103,000 after purchasing an additional 22,914 shares during the last quarter. 48.82% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply